Reconstituted Botulinum Type A Neurotoxin: Clinical Efficacy After Long-Term Freezing Before Use

被引:0
|
作者
Alan A. Parsa
Kevin D. Lye
Fereydoun Don Parsa
机构
[1] Seton Hall University School of Graduate Medical Education,Department of Internal Medicine
[2] St. Francis Medical Center,Department of Surgery, Division of Plastic Surgery
[3] John A. Burns School of Medicine,undefined
[4] University of Hawaii,undefined
来源
Aesthetic Plastic Surgery | 2007年 / 31卷
关键词
Botox; Botulinum neurotoxin; Effectiveness of Botox; Freezing preservation of Botox; Long-term storage of Botox; Side effects of Botox;
D O I
暂无
中图分类号
学科分类号
摘要
Botulinum neurotoxin type A (BoNT/A) is injected into muscles of facial expression for treatment of facial wrinkles. Manufacturers’ recommendations state that the product should be used within 4 h of reconstitution to prevent loss of effectiveness. A prospective study was undertaken to evaluate the effectiveness of reconstituted BoNT/A when preserved in a frozen state for up to 6 months, as compared with nonfrozen BoNT/A used within 4 h after reconstitution. Treatment of 118 sites in 80 patients was performed and evaluated for aesthetic efficacy. Excellent results were observed in 94.8% of sites treated with nonfrozen BoNT/A and in 93.3% of the sites treated with frozen and thawed BoNT/A (p = 1). Minor side effects were rare and transient in both groups. In contrast to common belief, reconstituted BoNT/A may be frozen, thawed, and injected without losing its potency for up to 6 months, with efficacy equivalent to that of freshly prepared BoNT/A.
引用
收藏
页码:188 / 191
页数:3
相关论文
共 50 条
  • [1] Reconstituted Botulinum Type A Neurotoxin: Clinical Efficacy After Long-Term Freezing Before Use
    Michael A. C. Kane
    Aesthetic Plastic Surgery, 2007, 31 : 192 - 193
  • [2] Reconstituted botulinum type A neurotoxin: Clinical efficacy after long-term freezing before use
    Parsa, Alan A.
    Lye, Kevin D.
    Parsa, Fereydoun Don
    AESTHETIC PLASTIC SURGERY, 2007, 31 (02) : 188 - 191
  • [3] Treatment of blepharospasm with botulinum neurotoxin type A: long-term results
    Calace, P
    Cortese, G
    Piscopo, R
    Della Volpe, G
    Gagliardi, V
    Magli, A
    De Berardinis, T
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2003, 13 (04) : 331 - 336
  • [4] Safety and efficacy of botulinum toxin type A following long-term use
    Naumann, M.
    Albanese, A.
    Heinen, F.
    Molenaers, G.
    Relja, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 35 - 40
  • [5] LONG-TERM EFFECTS OF BOTULINUM NEUROTOXIN TYPE A ON EXPERIMENTAL MUSCLE HYPERTONIA
    Matak, Ivica
    Sostaric, Petra
    TOXICON, 2021, 190 : S49 - S49
  • [6] High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy
    Albrecht, Philipp
    Jansen, Alexander
    Lee, John-Ih
    Moll, Marek
    Ringelstein, Marius
    Rosenthal, Dietmar
    Bigalke, Hans
    Aktas, Orhan
    Hartung, Hans-Peter
    Hefter, Harald
    NEUROLOGY, 2019, 92 (01) : E48 - E54
  • [7] Prevention of long-term disability with botulinum neurotoxin.
    Eshiett, MUA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R19 - R19
  • [8] Long-term use of botulinum toxin type A in the treatment of headaches
    Mauskop, A
    NEUROLOGY, 2002, 58 (07) : A497 - A497
  • [9] The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates
    Nestor, Mark S.
    Kleinfelder, Raymond E.
    Pickett, Andy
    DERMATOLOGIC SURGERY, 2017, 43 : S344 - S362
  • [10] Reader response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy
    Mulroy, Eoin
    Balint, Bettina
    Batla, Amit
    NEUROLOGY, 2019, 93 (17) : 768 - 768